A randomized comparison of four omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia

Alimentary Pharmacology and Therapeutics

Volumn 15, Issue 11, 2001, Pages 1787-1793

  Laurent, J ^a   Megraud F ^b   Flejou J F ^c   Caekaert, A ^d   Barthelemy P ^d  

^a Hôpital Pellegrin ^*  (France)

^b HÔPITAL PELLEGRIN   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; BACAMPICILLIN; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE;

ABDOMINAL PAIN; ANTIBIOTIC SENSITIVITY; ARTICLE; BREATH ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; ERADICATION THERAPY; FRANCE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TASTE DISORDER;

ADMINISTRATION, ORAL; ADULT; AMOXICILLIN; AMPICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; AZITHROMYCIN; BREATH TESTS; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; DYSPEPSIA; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; OMEPRAZOLE; PENICILLINS; TREATMENT OUTCOME; UREA;

EID: 0034773398     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2001.01104.x     Document Type: Article

References (31)

1. Current European concepts in the management of Helicobacter pylori infection. The Maastricht consensus report
2. Eradication of Helicobacter pylori using 1-week triple therapies combining omeprazole with two antimicrobials: The MACH 1 Study
3. The MACH2 Study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies
4. One-week triple therapy using omeprazole, amoxycillin and clarithromycin for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia: Influence of dosage of omeprazole and clarithromycin
5. Traitement de l'infection par Helicobacter pylori par lansoprazole 30 mg ou 60 mg associé à deux antibiotiques chez les ulcéreux duodénaux
6. Evaluation of short term ranitidine versus omeprazole triple therapy regimens for eradication of Helicobacter pylori in duodenal ulcer patients
7. Risk factors for failure of Helicobacter pylori therapy
8. Azithromycin levels in plasma and gastric tissue, juice and mucus
9. Helicobacter pylori et azithromycine
10. Three-day antibiotic therapy with azithromycin and tinidazole plus lansoprazole or pantoprazole to cure Helicobacter pylori infection: A pilot study
11. Azithromycin for the cure of Helicobacter pylori infection
12. A four-day low dose triple therapy regimen for the treatment of Helicobacter pylori infection
13. Helicobacter pylori eradication using one-week low-dose lansoprazole plus amoxycillin and either clarithromycin or azithromycin
14. Short-term low-dose triple therapy with azithromycin, metronidazole and lansoprazole appears highly effective for the eradication of Helicobacter pylori
15. Low- versus high-dose azithromycin triple therapy for Helicobacter pylori infection
16. The role of azithromycin in the treatment of Helicobacter pylori infection - A retrospective report
17. Dose-dependent absorption of amoxycillin and bacampicillin
18. Pharmacokinetics of bacampicillin compared with those of ampicillin, pivampicillin, and amoxycillin
19. Comparative pharmacokinetic study between lenampicillin, bacampicillin and amoxycillin
20. One week low-dose triple therapy for H. pylori: A multicentre, comparative study
21. Are one-week anti-H. pylori treatments more effective in patients with peptic ulcer disease (PUD) than in those with non-ulcer dyspepsia (NUD)? A meta-analysis
22. Resistance of Helicobacter pylori to antibiotics: The main limitation of current proton-pump inhibitor triple therapy
23. Survey of the in vitro susceptibility of Helicobacter pylori to antibiotics in France - Preliminary results
24. The DU-MACH study: Eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole-based triple therapy
25. The GU-MACH study: The effect of one-week omeprazole triple therapy on Helicobacter pylori infection. Eradication, healing and relapse in patients with active gastric ulcer
26. The OAC and OMC options
27. The Homer Study: The effect of increasing the dose of metronidazole when given with omeprazole and amoxicillin to cure Helicobacter pylori infection
28. Efficacy of two different dosage regimens of omeprazole, amoxycillin and metronidazole for the cure of Helicobacter pylori infection
29. Omeprazole, amoxycillin and metronidazole for the cure of Helicobacter pylori infection
30. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical activity
31. Prévalence de la résistance de Helicobacter pylori aux antibiotiques après échec de la triple thérapie amoxicilline-clarithromycine-oméprazole